Her primary areas of investigation include Immunology, T cell, Molecular biology, Antigen and Cytotoxic T cell. Her Immunology study frequently intersects with other fields, such as Cell biology. In her work, T-cell leukemia is strongly intertwined with Antibody, which is a subfield of T cell.
Her research in Molecular biology intersects with topics in Surface Immunoglobulin, B cell, Receptor, Immunoglobulin M and Lymphocyte. The various areas that Susan O. Sharrow examines in her Cytotoxic T cell study include Jurkat cells, Immune system, Immunoglobulin D, C57BL/6 and Spleen. Her work deals with themes such as Endocrinology and Lymphokine, which intersect with Interleukin 2.
Susan O. Sharrow mainly focuses on Molecular biology, Immunology, Antigen, T cell and CD8. Her Molecular biology study combines topics from a wide range of disciplines, such as Cell, Receptor, Spleen and Antibody, Monoclonal antibody. Her research in Immunology focuses on subjects like Cytotoxic T cell, which are connected to Transcription.
She studied Antigen and Lymphocyte that intersect with Surface Immunoglobulin. Her work on Antigen-presenting cell as part of general T cell study is frequently linked to Population, therefore connecting diverse disciplines of science. Her CD8 research incorporates elements of Cell biology, Cellular differentiation and T-cell receptor.
Her primary areas of study are CD8, Cell biology, T-cell receptor, T cell and Signal transduction. Her CD8 study combines topics in areas such as Cytotoxic T cell, Receptor, Transcription and Molecular biology. Her research integrates issues of Double negative and Biochemistry in her study of Molecular biology.
Her Cell biology research includes elements of Superantigen, Thymocyte, CD40, Immunology and Negative selection. Her T-cell receptor research incorporates themes from Major histocompatibility complex and Transgene. Her work in the fields of T cell, such as MHC class II, overlaps with other areas such as Population.
Her main research concerns T-cell receptor, Signal transduction, Immunology, CD8 and Cell biology. Her T-cell receptor research is multidisciplinary, incorporating perspectives in Tyrosine kinase and Major histocompatibility complex, Antigen. Her Immunology study frequently draws connections to adjacent fields such as Gene rearrangement.
Her CD8 research includes themes of Cytotoxic T cell and T cell. Within one scientific family, Susan O. Sharrow focuses on topics pertaining to Receptor under Cytotoxic T cell, and may sometimes address concerns connected to Molecular biology and Thymocyte. Her Molecular biology research focuses on subjects like In vivo, which are linked to Internal medicine and Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production.
M E Sanders;M W Makgoba;S O Sharrow;D Stephany.
Journal of Immunology (1988)
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.
M. T. Lotze;Y. L. Matory;S. E. Ettinghausen;A. A. Rayner.
Journal of Immunology (1985)
Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins.
S J Korsmeyer;A Arnold;A Bakhshi;J V Ravetch.
Journal of Clinical Investigation (1983)
Expression of interleukin 2 receptors on activated human B cells.
Thomas A. Waldmann;Carolyn K. Goldman;Richard J. Robb;Joel M. Depper.
Journal of Experimental Medicine (1984)
Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies.
J R Ortaldo;S O Sharrow;T Timonen;R B Herberman.
Journal of Immunology (1981)
Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing.
Crystal L. Mackall;Catherine V. Bare;Larry A. Granger;Susan O. Sharrow.
Journal of Immunology (1996)
In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2
M T Lotze;L W Frana;S O Sharrow;R J Robb.
Journal of Immunology (1985)
Texas red, a hydrophilic, red-emitting flourophore for use with flourescein in dual parameter flow microfluorometric and fluorescence microscopic studies
Julie A. Titus;Richard Haugland;Susan O. Sharrow;David M. Segal.
Journal of Immunological Methods (1982)
Negative selection of CD4+CD8+ thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28
J A Punt;B A Osborne;Y Takahama;S O Sharrow.
Journal of Experimental Medicine (1994)
Coreceptor Reversal in the Thymus: Signaled CD4+8+ Thymocytes Initially Terminate CD8 Transcription Even When Differentiating into CD8+ T Cells
Enrico Brugnera;Avinash Bhandoola;Ricardo Cibotti;Qing Yu.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: